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In adult mammalian brains, neurogenesis persists in
the subventricular zone of the lateral ventricles (SVZ)
and the dentate gyrus (DG) of the hippocampus.
Although evidence suggest that adult neurogenesis
in these two regions is subjected to differential regu-
lation, the underlyingmechanism is unclear. Here, we
show that the RNA-binding protein FXR2 specifically
regulates DG neurogenesis by reducing the stability
of NogginmRNA. FXR2 deficiency leads to increased
Noggin expression and subsequently reduced BMP
signaling, which results in increased proliferation
and altered fate specification of neural stem/progen-
itor cells in DG. In contrast, Noggin is not regulated
by FXR2 in the SVZ, because Noggin expression is
restricted to the ependymal cells of the lateral ventri-
cles, where FXR2 is not expressed. Differential regu-
lation of SVZ and DG stem cells by FXR2 may be
a key component of the mechanism that governs
the different neurogenic processes in these two adult
germinal zones.
INTRODUCTION
Adult mammalian brains have two neurogenic regions: the sub-
granular zone of the dentate gyrus (DG) of the hippocampus,
which generates excitatory glutamatergic granule neurons in
the DG, and the subventricular zone (SVZ) of the lateral ventri-
cles, which produces inhibitory GABAergic and dopaminergic
interneurons of the olfactory bulb (Lledo et al., 2006; Ming and
Song, 2005; Mu et al., 2010). Since the discovery of adult neuro-
genesis, DG and SVZ neurogenesis have been known to
respond differently to neurotrophic factors treatment and phys-
iological and pathological conditions (Li and Zhao, 2008; Zhao
et al., 2008). For example, environmental enrichment and phys-
ical activity boost neurogenesis in the DG, but not in the SVZ924 Neuron 70, 924–938, June 9, 2011 ª2011 Elsevier Inc.(Brown et al., 2003; Kempermann et al., 1997; Nilsson et al.,
1999). In addition, cranial irradiation represses cell proliferation
in both the SVZ and DG, but the DG suffers long-term effects,
whereas the SVZ recovers with time (Hellstrom et al., 2009).
Althoughmultipotent neural stem/progenitor cells (NPCs) exist
widely in adult brains, neurogenesis is known to be restricted by
the local stem cell niche (Goldman, 2004; Mu et al., 2010; Zhao
et al., 2008). However, recent literature suggests that NPCs
residing in different regions of the brain may be intrinsically pro-
grammed to differentiate into restricted types of neurons (Merkle
et al., 2007). NPCs derived from the adult SVZ (SVZ-NPCs) are
shown to have better self-renewal capability than do NPCs
derived from the adult DG (DG-NPCs) (Bull and Bartlett, 2005;
Seaberg and van der Kooy, 2002), which could be due to their
intrinsic differences in BMP signaling (Bonaguidi et al., 2008).
Nonetheless, despite these observations, the precise molecular
mechanism underlying the differential regulation of SVZ and DG
neurogenesis is still largely a mystery.
Fragile X relative protein 2 (FXR2) belongs to a family of fragile
X mental retardation proteins (FMRP, FXR1, and FXR2) that can
bind to RNA and associate with polyribosomes (Darnell et al.,
2009). These proteins share high sequence similarity in certain
functional domains but diverge in the C termini and in the nucle-
olar localization signal sequence, suggesting that they may
possess both overlapping and distinct functions (Coffee et al.,
2010; Kirkpatrick et al., 2001). FMRP and FXR2 are highly en-
riched in mammalian brains (Agulhon et al., 1999; Bakker et al.,
2000). Although only FMRP deficiency has been linked to human
fragile X syndrome, both FMRP and FXR2 mutant (KO) mice
exhibit fragile X-like behavioral deficits, including hippo-
campus-dependent learning impairment. Furthermore, FXR2
and FMRP double-mutant mice display exaggerated learning
deficits compared with single mutant mice (Bontekoe et al.,
2002; Brennan et al., 2006; Hayashi et al., 2007; Spencer et al.,
2006; Zhao et al., 2005). Since FMRP deficiency affects adult
hippocampal neurogenesis (Guo et al., 2011; Luo et al., 2010),
the behavioral phenotype of Fxr2 KO mice suggests that FXR2
may also regulate adult neurogenesis. Interestingly, Fxr2 KO
mice display learning impairments and changes in synaptic plas-
ticity that are somewhat distinct from those of FMRP-deficient
Figure 1. FXR2 Is Expressed in the NPCs of
the Adult DG and SVZ
(A and B) FXR2 is expressed in the SVZ (A) and the
DG (B). Red, FXR2; Blue, DAPI. Scale bars =
50 mm.
(C and D) FXR2 (red) is expressed in GFAP (white)
and Nestin (green) double-positive NPCs in the
SVZ (C) and the DG (D), as well as in a large
number of granule neurons (B and D). Arrows in C
and D point to FXR2+Nestin+GFAP+ cells. Arrow-
head in C points to FXR2+Nestin+GFAP cells.
Scale bar = 20 mm. The white dotted boxes indi-
cate the regions with high-magnification pictures
shown below (arrow: GFAP and Nestin double-
positive stem cells). See also Figure S1.
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FXR2 Regulates Adult NSCs via Nogginmice (Spencer et al., 2006; Zhang et al., 2009), indicating that
FXR2 may also regulate adult hippocampal neurogenesis via
mechanisms distinct from FMRP (Luo et al., 2010). Until now,
the role of FXR2 in the adult brain has not been well studied,
and its role in adult neurogenesis remains unexplored.
Here, we show that FXR2 deficiency leads to altered stem cell
proliferation and differentiation specifically in the DG and not in
the SVZ. We find that, in DG-NPCs, FXR2 represses the expres-
sion of Noggin, an antagonist of BMP signaling. Either reducing
the action of Noggin or enhancing BMP signaling rescues the
stem cell phenotypes resulting from FXR2 deficiency. In the
SVZ, however, Noggin expression is restricted to ependymal
cells, whereFXR2 is not expressed; therefore, Noggin expression
is not regulated by FXR2. Our study reveals a regulatory mecha-
nism of adult hippocampal neurogenesis by the brain-enriched
RNA-binding protein FXR2. The differential regulation of SVZ
and DG stem cells by FXR2 may be a key component of the
mechanism governing the differential neurogenic processes in
these two adult germinal zones.
RESULTS
FXR2 Deficiency Affects NPC Proliferation
and Differentiation in the DG but Not in the SVZ
To investigate the role of FXR2 in adult neural stem cells, we first
demonstrated that FXR2 is indeed expressed in the two adultNeuron 70, 924–germinal zones, SVZ (Figure 1A) and the
DG (Figure 1B). We detected FXR2
expression inmost of the granule neurons
in the DG with no compensatory
increased expression of FMRP in Fxr2
KOmice (see Figure S1A available online),
which is consistent with the literature
(Bakker et al., 2000; Bontekoe et al.,
2002). In both the SVZ and DG, FXR2
was localized in Nestin-positive (Nestin+)
NPCs, Nestin and GFAP double-positive
(Nestin+GFAP+) radial glia-like NPCs,
and double-cortin-positive (DCX+) imma-
ture neurons (Figures 1C and 1D; Fig-
ure S1B), but not in either astrocytes or
oligodendrocytes (Figures S1C–S1E).To explore the function of FXR2 in adult neurogenesis, we as-
sessed the proliferation and differentiation of NPCs in Fxr2 KO
mice and wild-type (WT) controls using a saturation BrdU
pulse-labeling method that could label the entire pool of prolifer-
ating NPCs within a 12 hr period (Figure 2A) (Hayes and Nowa-
kowski, 2002; Luo et al., 2010). Quantitative analysis at 12 hr
following the last BrdU injection showed that, in the DG of
the hippocampus, Fxr2 KO mice had 20% more BrdU+ cells
compared with WT littermates (Figures 2B and 2C; n = 6,
p < 0.05). Nestin+ immature cells in the DG are known to contain
at least two populations: Nestin+GFAP+ radial glia-like cells (also
called type 1; Figure 2D) and Nestin+GFAP nonradial glia-like
cells (also called type 2a; Figure 2G). Both types can incorporate
BrdU (Ables et al., 2010; Kempermann et al., 2004; Ming and
Song, 2005). In the Fxr2 KO DG, both total Nestin+ cells (n = 6,
p < 0.001) and Nestin+GFAP+ radial glia-like NPCs (Figures 2E
and 2F; n = 6, p < 0.001) exhibited increased BrdU incorporation,
whereas Nestin+GFAP nonradial glia-like NPCs did not (Fig-
ure 2H; n = 6, p = 0.7313). The volume (size) of the DG did not
differ between WT and Fxr2 KO mice (data not shown). These
results indicate that FXR2 deficiency leads to increased prolifer-
ation of radial glia-like NPCs in the adult DG.
We next assessed the fate of new cells in the DG at one week
after BrdU injection. We found that FXR2-deficient mice still had
25%more BrdU+ cells (Figures 2B and 2C; n = 5, p < 0.05) and
that the survival rate of BrdU+ cells from 12 hr to one week after938, June 9, 2011 ª2011 Elsevier Inc. 925
Figure 2. FXR2 Deficiency Affects Stem Cell Proliferation and Differentiation in the Adult DG but Not in the SVZ
(A) Experimental scheme for assessing neural stem cell proliferation and early stage new cell survival and differentiation in adult mice.
(B) Examples of WT and Fxr2 KO brain sections stained with an antibody against BrdU (red) and DAPI (blue) for in vivo hippocampal cell proliferation and
differentiation analyses. Scale bars = 50 mm.
(C) Quantification of the number of BrdU+ cells in the DG normalized to volume of the DG. Fxr2 KO mice showed increased BrdU incorporation indicating
proliferation analyzed at 12 hr after the last BrdU injection compared withWTmice (p < 0.05, n = 6). There were still more BrdU+ cells in the DG of Fxr2 KOmice
when analyzed at one week after BrdU injection (p < 0.05, n = 5).
(D) Example of a Nestin+ (green), GFAP+ (blue), and BrdU+ (red) cell used for quantification in E and F. This cell is localized in a brain section analyzed at 12 hr after
BrdU injection.
(E and F) The DG of Fxr2 KOmice exhibited increased proliferation (E) and the total number (F) of radial glia-like NPCs (BrdU+Nestin+GFAP+) analyzed at 12 hr after
the last BrdU injection (n = 6 WT; n = 6 KO).
(G) Example of a Nestin+ (green), GFAP (blue), and BrdU+ (red) cell used for quantification in H at 12 hr after BrdU injection.
(H) TheDGofFxr2KOmice exhibited no change in nonradial glia-like NPCsBrdU+Nestin+GFAP) analyzed at 12 hr after the last BrdU injection (n = 6WT; n = 6KO).
(I) Examples of brain sections stained with antibodies against immature neuronal marker DCX (green) and BrdU (red) at one week after BrdU injection to assess
early stage neuronal differentiation. Scale bars = 20 mm.
(J) A higher percentage of BrdU+ cells in the DG of Fxr2 KOmice were DCX+, suggesting increased neuronal differentiation compared withWTmice at one week
after BrdU injection (n = 6, p < 0.01).
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FXR2 Regulates Adult NSCs via NogginBrdU injection was no different between WT and Fxr2 KO mice
(n = 6, p = 0.99). On the other hand, BrdU+ cells in the Fxr2 KO
DG differentiated into more DCX+ neurons compared with WT
mice (Figures 2I and 2J; n = 6, p < 0.001). Therefore, FXR2 defi-
ciency leads to enhanced proliferation and neuronal differentia-
tion of NPCs in the DG, without affecting the short-term survival
of new cells.
We then assessed neurogenesis in the SVZ of adult Fxr2 KO
mice. To our surprise, Fxr2 KOmice showed no significant differ-
ences in BrdU incorporation (Figure 2K; n = 5, p = 0.525) and the
proliferation of either Nestin+GFAP+ cells (Figure 2L; n = 6, p =
0.6472) or Nestin+GFAP cells (n = 6, p = 0.8538) compared to
WT mice. Furthermore, at one week after BrdU injection, the
percentage of DCX+ neuroblasts amongBrdU+ cells in the rostral
migratory stream (RMS, Figure 2M) was essentially the same for
WT and Fxr2 KO mice (n = 5, p = 0.8871). Taken together, these
results suggest that the loss of FXR2 specifically alters neuro-
genesis in the adult DG, but not in the adult SVZ.
FXR2 Regulates the Proliferation and Differentiation
of NPCs Derived from the Adult DG, but Not Those
from the SVZ
To determine whether the different phenotypes in the DG and
SVZ in the Fxr2 KO mice were due to intrinsic differences in
NPCs, we isolated NPCs from both regions (Figures 3A and
3J). Early passage primary NPCs isolated from both DG and
SVZ were positive for the progenitor markers Nestin and Sox2
(Figure 3B) and expressed FXR2 (Figure S2A and S2B). In fact,
96.7% ± 0.84% of total cultured NPCs and 98.8% ± 0.82% of
Nestin+Sox2+ NPCs expressed FXR2 (Figure S2C).
We found that Fxr2 KODG-NPCs exhibited significantly higher
BrdU incorporation compared with WT cells, particularly in the
Sox2/Nestin double-positive populations (Figures 3C and 3D;
n = 3, p < 0.05). In addition, DG-NPCs isolated from Fxr2 KO
brains yielded 25% more primary neurospheres that were
40% larger (in diameter) than WT controls (Figures 3E–3G;
n = 3, p < 0.001). To determine the self-renewal capability of
these neurospheres, primary spheres were individually dissoci-
ated into single cells and plated at clonal density. Fxr2 KO DG-
NPCs yielded 40% more secondary and tertiary spheres with
30% increased size compared to WT cells (Figures 3H and
3I; n = 3, p < 0.001). These results indicate that FXR2 deficiency
leads to increased proliferation and self-renewal of DG-NPCs.
However, SVZ-NPCs derived from WT and Fxr2 KO mice
(Figure 3J) had the same BrdU incorporation rate (n = 3, p =
0.8268) and displayed the same primary neurosphere formation
as well as similar self-renewal abilities (n = 3, p > 0.05; Figures
S2D–S2F). Therefore, FXR2 deficiency does not affect the self-
renewal of SVZ-NPCs.(K) Examples ofWT and Fxr2 KO brain sections stained with an antibody against
after BrdU injection. Scale bars = 20 mm.
(L) Brain regions containing the SVZ were labeled with antibodies against Nestin (
20 mm.
(M) Brain sections containing the rostral migratory stream (RMS) were stained
injection.
Data are presented as mean ± SEM; *p < 0.05, **p < 0.01, Student’s t test. ScaleConsistent with our in vivo findings, Fxr2 KO DG-NPCs ex-
hibited a 30% increase in neuronal differentiation (Figures 4A
and 4B; n = 3, p < 0.001) and a 60% decrease in astrocyte
differentiation (Figures 4D and 4E; n = 3, p < 0.001) compared
with WT controls. The reduction in astrocyte differentiation was
not a result of increased death of GFAP+ astrocytes (Figures
S2G and S2H). To validate our immunocytochemical data, we
assessed differentiation of NPCs by measuring the promoter
activity of a pan-neuronal transcription factor, Neurogenic differ-
entiation 1 (NeuroD1) and the promoter activity of astrocyte
GFAP (Liu et al., 2010; Luo et al., 2010). In Fxr2 KO DG-NPCs,
NeuroD1 promoter activity increased by 30% (Figure 4C; n =
3, p < 0.05), while GFAP promoter activity decreased by 70%
(Figure 4F; n = 3, p < 0.001). On the other hand, SVZ-NPCs
derived from Fxr2 KO mice showed no significant difference in
either neuronal or astrocyte differentiation compared with WT
cells (n = 3, p > 0.5). Next, we found that expressing exogenous
FXR2 in Fxr2 KO DG-NPCs rescued the proliferation (Figure 4G;
n = 3, p < 0.05), neuronal differentiation (Figure 4H; n = 3,
p < 0.05), and astrocyte differentiation (Figure 4I; n = 3, p <
0.05) deficits of Fxr2 KO DG-NPCs. Therefore, FXR2 regulation
of DG-NPCs is likely intrinsic to the NPCs.
Even though Fxr2 KO mice exhibit no obvious deficits during
embryonic development (Bontekoe et al., 2002), FXR2 defi-
ciency may nonetheless have a developmental impact on adult
NPCs. We therefore acutely knocked down FXR2 in adult
DG-NPCs using lentivirus expressing a small inhibitory RNA
against FXR2 (shFXR2; Figure S3A), which resulted in increased
proliferation, increased neuronal differentiation, and decreased
astrocyte differentiation (Figures S3B–S3D; n = 3, p < 0.05).
We then acutely deleted FXR2 in NPCs in the DG of the adult
WT mice using retrovirus that only infected dividing cells (Liu
et al., 2010; Smrt et al., 2010) (Figures S3E–S3H). Viral infection
resulted in increased proliferation (Figures S3I–S3M) and
increased neuronal differentiation (Figure S3N). Therefore, acute
knockdown of FXR2 in adult NPCs results in phenotypes similar
to those we observed in Fxr2 KO NPCs, both in vitro and in vivo.
Taken together, our results provide further evidence that FXR2
plays a role in regulating the proliferation and differentiation of
NPCs specifically in the adult DG.
FXR2 Represses Noggin Protein Expression in DG-NPCs
To determine how FXR2 regulates NPCs in the DG, we first used
real-time PCR-based neural stem cell pathway arrays to identify
genes that exhibited altered expression levels in Fxr2 KO
DG-NPCs relative to WT cells (Figure S4A). Among the genes
with >2-fold changes in Fxr2 KO DG-NPCs (Figure S4B), we
selected Shh (sonic hedgehog), Notch2 (Notch gene homolog
2), Sox3 (SRY-box containing gene 3), and Noggin for furtherBrdU (red) for in vivo SVZ cell proliferation and differentiation analyses at 12 hr
green), GFAP (white), and BrdU (red) at 12 hr after BrdU injection. Scale bars =
with antibodies against DCX (green) and BrdU (red) at one week after BrdU
bars = 20 mm.
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Figure 3. Loss of FXR2 Leads to Increased Proliferation of DG-NPCs but Not SVZ-NPCs
(A) Schematic drawing showing the isolation of DG-NPCs. Special care was taken to avoid any contamination from lateral ventricles.
(B) Both WT and KO DG-NPCs incorporated BrdU (white) during a 16 hr BrdU pulse labeling under proliferating conditions and expressed neural progenitor
markers Nestin (Green) and Sox2 (Red). Scale bars = 20 mm.
(C and D) Quantitative analysis showing that Fxr2 KO DG-NPCs, particularly those Nestin and Sox2 double-positive cells (D), incorporated more BrdU compared
withWT controls (n = 3).
(E) Sample images of DG-NPC neurospheres isolated from Fxr2 KO and WT mice. Scale bars = 100 mm.
(F and G) Fxr2 KO DG yielded more primary neurospheres (F) with larger sizes (G) thanWT DG (n = 3).
(H and I) The self-renewal ability of neurospheres isolated fromWT andKO adult DGwas assessed by secondary and tertiary neurosphere formation. Fxr2 KODG-
NPCs had increased self-renewal ability, as demonstrated by the increased of number (H) and size (I) of neurospheres compared with WT (n = 3).
(J) Schematic drawing showing the isolation of adult SVZ-NPCs.
Data are presented as mean ± SEM; *p < 0.05, **p < 0.01, Student’s t test. See also Figure S2 and Figure S3.
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FXR2 Regulates Adult NSCs via Nogginanalyses, due to their well-known functions in NPCs (Lim et al.,
2000; Ninkovic and Gotz, 2007; Palma et al., 2005; Solecki
et al., 2001; Wang et al., 2006). The up-regulation of Noggin in
Fxr2 KO DG-NPCs was particularly interesting, because Noggin
has been shown to promote the self-renewal of DG-NPCs, but
not SVZ-NPCs (Bonaguidi et al., 2008).928 Neuron 70, 924–938, June 9, 2011 ª2011 Elsevier Inc.FXR2 is known to bindmRNAs and regulate protein translation
(Darnell et al., 2009; Kirkpatrick et al., 2001). Using immunopre-
cipitation of FXR2 and its bound RNAs (RNA-IP), we confirmed
that FXR2 bound to Noggin mRNA (Figures 5A and 5B) but not
to Shh, Notch2, or Sox3 mRNAs (Figure S4C). In addition,
biotin-labeled synthetic Noggin mRNA indeed bound FXR2
Figure 4. Loss of FXR2 Leads to Increased
Neuronal but Decreased Astrocyte Differen-
tiation of DG-NPCs but Not of SVZ-NPCs
(A–C) Fxr2 KO DG-NPCs differentiated into more
neurons as demonstrated by immunostaining cells
using neuronal marker Tuj1+ (A red) followed by
quantitative analysis of Tuj1+ cells (B), as well as
transfected NeuroD1 promoter activity (C). A co-
transfected Renilla luciferase (R-Luc) plasmid was
used as a transfection control (n = 3). Scale bars =
20 mm.
(D–F) Fxr2 KO NPCs from the DG differentiated
into fewer GFAP+ astrocytes as shown by
a reduced percentage of GFAP+ cells (D and E)
and reduced GFAP promoter activity (F) (n = 3).
Scale bars = 20 mm.
(G–I) Introducing exogenous FXR2 into Fxr2
KO DG-NPCs corrected the proliferation (G),
neuronal differentiation (H), and astrocyte differ-
entiation (I) deficits of Fxr2 KO NPCs to the WT
levels. (n = 3).
Data are presented as mean ± SEM; *p < 0.05,
**p < 0.01, Student’s t test. See also Figure S2.
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FXR2 Regulates Adult NSCs via Nogginprotein in NSC protein lysate, whereas an antisense control RNA
did not (Figure 5C). Furthermore, on separately isolated DG-
NPCs, we confirmed that Noggin mRNA levels were elevated
in the Fxr2 KO DG-NPCs (Figure 5D). The increased Noggin
mRNA levels could be due to either increased gene transcription
or increased mRNA stability. We treatedWT and KO NPCs with
actinomycin D to inhibit gene transcription and found that
Noggin mRNA had a longer half-life in Fxr2 KO DG-NPCs than
in WT cells (Figure 5E; n = 3), while the half-life of Notch2, Shh,
and Sox3 mRNA showed no significant difference (Figures
S4D–S4F). We then manipulated FXR2 levels in WT and Fxr2
KO DG-NPCs and found that acute knockdown of FXR2 in WT
NPCs resulted in a longer half-life of Noggin mRNA, while exog-
enous FXR2 reduced the Noggin mRNA half-life in Fxr2 KO DG-
NPCs (Figure 5E). Therefore, FXR2 expression levels directly
affect the stability of Noggin mRNA in DG-NPCs. Finally, we
confirmed that primary DG-NPCs express both FXR2 and
Noggin protein (Figure S5A) and that the level of Noggin protein
was significantly higher in both the cell lysate and the condi-
tioned medium of Fxr2 KO DG-NPCs, compared with WT cells
(Figures 5F and 5G). Therefore, FXR2 represses Noggin protein
expression in DG-NPCs by decreasing the half-life of Noggin
mRNA.
Noggin inhibits BMP signaling by preventing BMP from inter-
acting with their receptors (Figure 5H) (Klingensmith et al.,
2010; Rosen, 2006). Accordingly, we assessed the activity of
the BMP signaling in Fxr2 KO DG-NPCs by analyzing the phos-
phorylation of Smad1/5 (p-Smad1/5), an indicator of BMP
pathway activation (Miyazono et al., 2005). We found that KO
DG-NPCs had a reduced ratio of p-Smad1/5 compared with
total Smad1/5 (Figure 5I). Introducing exogenous FXR2 into
Fxr2 KO DG-NPCs resulted in rescue of both secreted Noggin
protein levels (Figure 5J) and p-Smad1/5 levels (Figure 5K; Fig-ure S5B). On the other hand, acute knockdown of FXR2 in WT
DG-NPCs resulted in increased secreted Noggin protein (Fig-
ure 5L), as well as reduced p-Smad1/5 (Figure 5M; Figure S5C).
Therefore, FXR2 regulates the BMP signaling in DG-NPCs by
controlling Noggin levels.
Since FXR2 is highly expressed in DG neurons, we also
assessed BMP signaling in hippocampal tissue (Figures S5D–
S5F). Indeed, Noggin protein levels were significantly higher
(Figure S5G), while p-Smad1/5 levels were significantly lower
(Figure S5H) in the hippocampal tissue of Fxr2 KO mice
compared with WT mice. Thus, by inhibiting Noggin protein
expression, FXR2 promotes BMP signaling in both DG-NPCs
and in the hippocampus.
Manipulating BMP Signaling Rescues Deficits
in FXR2-Deficeient DG-NPCs
We reasoned that either adding exogenous BMP2 or blocking
endogenous Noggin should rescue the phenotypes of Fxr2 KO
DG-NPCs (Figure 6A). Indeed, BMP2 treatment reduced the
high proliferation rate of Fxr2 KO DG-NPCs (Figures 6B and
6C; n = 3) and rescued both the neuronal (Figures 6D and 6E;
n = 3) and astrocyte (Figures 6F and 6G; n = 3) differentiation
phenotypes of Fxr2 KO DG-NPCs to the WT control levels. In
addition, an anti-Noggin blocking antibody rescued the prolifer-
ation and differentiation deficits of Fxr2 KO DG-NPCs (Figures
6H–6K; n = 3). Next, to confirm that enhancedNoggin expression
by Fxr2 KO DG-NPCs indeed had a biological effect on NPC
functions, we treated WT DG-NPCs with conditioned medium
collected from Fxr2 KO DG-NPCs. The conditioned medium
fromKOcells promoted the proliferation ofWT cells, which could
be blocked by an anti-Noggin blocking antibody (Figure S5I and
S5J). Therefore, Noggin and BMP signaling are likely down-
stream effectors of FXR2 in the regulation of DG neurogenesis.Neuron 70, 924–938, June 9, 2011 ª2011 Elsevier Inc. 929
Figure 5. FXR2 Regulates Noggin Expression in DG-NPCs
(A) Western blot analysis showing the presence of FXR2 in both the input and the antibody immunoprecipitated FXR2-containingmRNA complexes (RNA-IP) from
bothWT and Fxr2 KO DG-NPCs.
(B) RT-PCR analysis of input and FXR2-IP RNAs indicated that FXR2 could bind to Noggin mRNA in WT DG-NPCs. GAPDH mRNA was used as a control.
(C) Biotin-labeled synthetic Noggin mRNA (S), but not a control antisense RNA (AS) pulled down FXR2 protein from DG-NPC lysates. Western blot analysis
showing the presence of FXR2 in both the input and Noggin sense mRNA pull-down conditions.
(D) DG-NPCs derived from Fxr2 KO mice had elevated Noggin mRNA levels as assessed by real-time PCR analysis (p < 0.05; n = 3).
(E) DG-NPCs were treated with actinomycin D to inhibit gene transcription, and the percentage of NogginmRNA in NPCs was quantified using real-time PCR at
the indicated time point (n = 3). FXR2 deficiency (Fxr2 KO or WT+shFXR2) resulted in increased Noggin mRNA stability, whereas elevated FXR2 expression
(WT+FXR2 or KO+FXR2) led to decreased Noggin mRNA stability.
(F) Western blot analysis and quantification showing that the Noggin protein level was increased in Fxr2 KO DG-NPCs compared withWT cells (n = 3, p < 0.01).
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FXR2 Regulates Adult NSCs via NogginNoggin has been shown to promote the self-renewal of type 1
cells in the DG (Bonaguidi et al., 2008). We therefore hypothe-
sized that elevated Noggin levels might be responsible for the
increased cell proliferation we observed in Fxr2 KO mice.
Accordingly, we investigated whether reducing endogenous
Noggin in the DG could rescue the neurogenic phenotype of
Fxr2 KO mice (Figures S6A–S6C). The lentivirus expressing
either a shRNA against Noggin (shNog) or a control shRNA
(shNC), as well as GFP, were injected into the DG of Fxr2 KO
and WT littermates (Figure 7A) based on a published protocol
(Clelland et al., 2009). We waited for two weeks after lentiviral
grafting to allow for sufficient depletion of endogenous Noggin
before givingmice BrdU.We saw that, in animals with successful
viral grafting, which therefore were used for data analysis, a large
number of DG cells were infected by the recombinant lentivirus in
bothWT and KOmice (GFP+ cells in Figure S6D and Figures 7B,
7F, and 7I). Lenti-shNog-infected cells had reduced levels of
Noggin protein (Figure S6E). As expected, reduction of Noggin
in the DG had a significant effect on the proliferation of DG-
NPCs, as assessed at both 12 hr (Figure 7C) and one week (Fig-
ure 7D) after BrdU injection, with no effect on the survival of
BrdU+ cells (Figure 7E). The effect of shNog on cell proliferation
was, at least in part, due to its effect on the GFAP+ radial glia-like
population (Figures 7F–7H; Figure S6F), which is similar to the
function of FXR2. In addition, acute knockdown of Noggin re-
sulted in enhanced neuronal differentiation of adult NPCs and,
hence, enhanced the number of new neurons analyzed at one
week after BrdU injection (Figures 7I–7K). Furthermore, knocking
down endogenous Noggin in adult Fxr2 KOmice (KO+shNog) led
to significantly decreased NPC proliferation (Figures 7C–7H) and
neuronal differentiation (Figures 7J and 7K) to levels similar toWT
controls (WT+shNC). These in vivo data further support the
model that FXR2 regulates DG neurogenesis by repressing
Noggin protein levels.
FXR2 and Noggin Colocalize in DG but Not in SVZ Cells
Next, we investigated why FXR2 deficiency had no effect on
SVZ-NPCs. Although FXR2 was expressed at comparable levels
in both SVZ-NPCs and DG-NPCs, we were only able to detect
extremely low levels of Noggin protein in SVZ-NPCs, and the
expression levels of Noggin were no different between cultured
WT and KO SVZ-NPCs (Figure S7A). In addition, KO SVZ-
NPCs did not show altered p-Smad1/5 levels compared
with WT cells (Figure S7B), suggesting that FXR2 deficiency
does not alter either Noggin expression or BMP signaling in
SVZ-NPCs. The lack of effect from FXR2 deficiency on Noggin
and BMP signaling in SVZ-NPCs could have two possible expla-
nations: (1) Noggin and the BMP pathway do not regulate the
functions of SVZ cells as they do in the case of DG cells; or (2)(G) Conditioned medium from Fxr2 KO DG-NPCs displayed significantly elevated
(H) Schematic drawing of Noggin and BMP signaling pathway in DG-NPCs.
(I) The levels of p-Smad1/5 (ratio of p-Smad1/5 over total Smad1/5), an indicator o
(n = 3, p < 0.01). See also Figure S4.
(J and K) Exogenous FXR2 rescued the secreted Noggin protein levels (J) as we
(L and M) Acute knockdown of FXR2 in WT DG-NPCs led to increased secreted
Data are presented as mean ± SEM; *p < 0.05, **p < 0.01, Student’s t test.FXR2 does not regulate Noggin expression, and therefore BMP
signaling in SVZ cells as it does in DG cells.
To distinguish between these two hypotheses, we first
assessed the effects of exogenous Noggin and BMP2 on
SVZ-NPCs, compared with DG-NPCs. We found that exogenous
Noggin promoted the proliferation of DG-NPCs (Figure S7F),
but not SVZ-NPCs (Figure S7C), consistent with literature (Bona-
guidi et al., 2008; Lim et al., 2000). On the other hand, Noggin
promotedneuronaldifferentiationanddecreasedastrocytediffer-
entiation in both SVZ-NPCs (FiguresS7D andS7E) andDG-NPCs
(Figures S7G and S7H) to similar extents, consistent with its
reported role in inhibiting glia cell fate (Chmielnicki et al., 2004;
Kohyama et al., 2010; Lim et al., 2000). We then found that
exogenous BMP2 inhibited proliferation, repressed neuronal
differentiation, and promoted astrocyte fate to similar extents
in both WT and KO SVZ-NPCs (Figures S7I–S7K). Therefore,
BMP2 had similar effects on both DG-NPCs (Figures 6B–6G)
andSVZ-NPCs.We therefore predicted that FXR2must not regu-
late Noggin expression in SVZ-NPCs as it does in DG-NPCs.
To assess this possibility, we first confirmed that FXR2 indeed
does not bindNogginmRNA in SVZ-NPCs (Figure S7L). Because
FXR2 and Noggin are expressed in both the DG and SVZ, we
reasoned that a lack of FXR2 regulation of Noggin in the SVZ
might be due to cell type-restricted expression of these two
proteins. To precisely identify the cells expressing Noggin, we
used both Noggin antibody staining and a transgenic ‘‘knock-
in’’ mouse strain expressing b-gal under the Noggin promoter
(NogginlacZ) (McMahon et al., 1998). Expression of b-gal in this
strain is an accurate and precise reporter of Noggin expression
(Stottmann et al., 2001). Indeed, we found that FXR2 and Noggin
are not colocalized in the same cells in the SVZ (Figure 8A;
Figures S8A–S8C). Noggin expression is restricted to s100b+
ependymal cells that also express Nestin (Figures 8B and 8C,
Figure S8B), consistent with a previous report (Lim et al., 2000).
By contrast, FXR2 is expressed only in s100b-negative NPCs
(Figures 1, 8A, and 8C; Figure S8C), and not in s100b+Nestin+
ependymal cells (Figures 8A and 8B; Figure S8A).
In the DG, however, we found that Noggin is expressed in
Nestin+GFAP+ radial glia-like NPCs (Figure 8E; Figures S8E and
S8G), consistent with an earlier study (Bonaguidi et al., 2008).
Importantly, these cells also express FXR2 (Figure 1), and FXR2
expression colocalizes with Noggin in both NPCs and neurons
of theDG(Figure8D;FiguresS8DandS8F). Thesespatiotemporal
expressiondata further support the regulatory role of FXR2 inDG-
NPCs, but not in SVZ-NPCs. Taken together, our data argue for
amodel inwhich FXR2specifically regulatesDG-NPCsbydirectly
repressing Noggin expression in DG-NPCs. Because Noggin
expression in the SVZ is not regulated by FXR2, FXR2 deficiency
therefore has minimal impact on SVZ-NPCs (Figures 8F and 8G).Noggin levels determined using an ELSA assay (n = 3, p < 0.05).
f BMP signaling, were decreased in Fxr2 KODG-NPCs compared withWT cells
ll as Smad1/5 phosphorylation (K).
Noggin protein levels (L) and decreased Smad1/5 phosphorylation (M).
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Figure 6. Manipulation of BMP Signaling Rescues Phenotypes of FXR2-Deficient DG-NPCs
(A) Schematic drawing showing that both adding exogenous BMP2 and blocking endogenous Noggin should affect intracellular BMP signaling.
(B) Both WT and KO NPCs incorporated BrdU (red) under proliferating conditions with or without exogenous BMP2. Scale bar = 20 mm.
(C) Quantitative analysis showing that exogenous BMP2 reduced the high proliferation rate of Fxr2 KO DG-NPCs to the WT control levels (n = 3, p < 0.05).
(D and F) Differentiating DG-NPCs with or without BMP2 treatment were analyzed using antibodies against Tuj1+ (D, red) for neurons and GFAP+ (G, green) for
astrocytes. Scale bar = 20 mm.
(E and G) Quantification analyses of differentiated DG-NPCs demonstrate that exogenous BMP2 rescued the neuronal (E) and astrocyte (G) differentiation
phenotypes of Fxr2 KO DG-NPCs (n = 3, p < 0.05).
(H) Schematic drawing showing that a Noggin-blocking antibody should block Noggin activity and enhance BMP signaling.
(I–K) Quantification analysis showing that Noggin blocking antibody rescued the proliferation (I), neuronal differentiation (J), and astrocyte differentiation (K)
phenotypes of Fxr2 KO DG-NPCs (n = 3, p < 0.05). Data are presented as mean ± SEM; *p < 0.05, **p < 0.01, Student’s t test.
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Figure 7. Knocking Down Endogenous
Noggin in the DG Rescues the Proliferation
and Differentiation Deficits of DG-NPCs
(A) Experimental scheme for assessing the effect
of knocking down endogenous Noggin expression
using lentivirus-shRNA on neural stem cell prolif-
eration and differentiation in the adult DG.
(B) Examples of an adult hippocampal brain
section stained with an antibody against GFP
(green), BrdU (red), and DAPI (blue) for in vivo
proliferation analyses.
(C and D) Knocking down Noggin could rescue the
proliferation deficits of Fxr2 KO mice to similar
levels as in WT mice as determined both at 12 hr
(C, n = 3, p < 0.05) and at one week after BrdU (D,
n = 3, p < 0.05 and p < 0.01) injection.
(E) There is no difference in the survival of BrdU+
cells from 12 hr to one week in all conditions.
(F) Examples of an adult hippocampal brain
section stained with an antibody against GFP
(green), GFAP+ (red), BrdU (white), and DAPI
(blue). Arrow points to a cell that is positive for all
markers.
(G and H) Knocking down Noggin rescued the
proliferation deficits of radial glia-like NPCs (G,
percentage of GFAP+BrdU+/BrdU+ cells) and the
total number radial glia-like NPCs (H, GFAP+
BrdU+ cells) of Fxr2 KO mice to levels similar to
those of WT mice (n = 3, p < 0.05).
(I) Examples of an adult hippocampal brain section
stained with an antibody against GFP (green),
DCX+ (red), BrdU (white), and DAPI (blue). Arrows
point to cells that is positive for all markers.
(J and K) Knocking down Noggin could rescue the
neuronal differentiation deficits (J, percentage of
DCX+BrdU+/BrdU+ cells) and the total number of
new young neurons (K, DCX+ cells) of Fxr2 KO
mice to levels similar to those of WT mice (n = 3,
p < 0.05).
Data are presented as mean ± SEM; *p < 0.05,
**p < 0.01, Student’s t test. Scale bars in B =
20 mm. Scale bars in F and I = 10 mm. See also
Figure S5.
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The molecular mechanism behind the differential regulation
of SVZ and DG neurogenesis has gone largely unexplored. By
unveiling a regulatory mechanism involving FXR2 that governs
adult hippocampal neurogenesis, our data show that a brain-en-
riched RNA-binding protein could play important roles in the
differential regulation of NPCs residing in different brain regions.Neuron 70, 924–Both the Extrinsic Stem Cell Niche
and Intrinsic NPC Properties May
Contribute to the Differences
between Adult DG and SVZ
Neurogenesis
A limited number of publications have
analyzed both DG and SVZ neurogenesis
and reported different phenotypes
between these two regions (Belvindrahet al., 2002; Liu et al., 2007). However, the molecular mechanism
underlying the differences between DG and SVZ neurogenesis is
largely a mystery.
The cytoarchitecture of the two adult neurogenic regions are
quite different. There are four key cell types in the SVZ: ciliated
ependymal cells that face the ventricle lumen, providing a
barrier and filtration system for cerebrospinal fluid; slowly prolif-
erating stem cells; actively proliferating progenitor cells; and938, June 9, 2011 ª2011 Elsevier Inc. 933
Figure 8. Noggin and FXR2 Are Colocalized in the DG but Not in the SVZ
(A) Noggin (as shown by b-gal staining in NogginlacZ mice) and FXR2 were not expressed in the same cells of the SVZ.
(B) Noggin (red) is expressed in S100b+ ependymal cells (green) in the SVZ.
(C) Since ependymal cells also expressed Nestin (green), Noggin (red) partially overlaps with Nestin. However, Noggin is not expressed in GFAP (white) or Nestin
double-positive stem cells in the SVZ. Blue, DAPI.
(D) Noggin (red) and FXR2 (green) were coexpressed in the same cells of the DG. Noggin (red) is expressed in GFAP+ (green) radial glia-like NPCs in the DG.
(E) Noggin (red) is expressed in GFAP+ and Nestin (green) double-positive radial glia-like NPCs in the DG.
(F and G) Models of FXR2 and Noggin function in adult SVZ (F) and DG (G) NPCs. In the SVZ (F), Noggin is expressed by ependymal cells, while FXR2 is
expressed by stem cells; therefore, FXR2 does not regulate Noggin expression. However, in the DG (G), FXR2 and Noggin are coexpressed in the stem cells (and
also granule neurons); therefore, the expression levels of Noggin are under FXR2 control. FXR2 thus specifically regulates the fate of DG-NPCs by repressing
Noggin expression, thereby enhancing BMP signaling. All scale bars = 20 mm. See also Figure S6 and Figure S7.
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Ependymal cells were proposed to be SVZ stem cells (Johans-
son et al., 1999), but mounting evidence indicates that ependy-
mal cells are not proliferative and do not have the properties of
NPCs (Capela and Temple, 2002; Doetsch et al., 1999). Since
FXR2 expression is restricted to NPCs and Noggin expression
is restricted to the ependymal cells, this differential expression
prevents the direct regulation of Noggin expression by FXR2.
We detected very low levels of Noggin protein in the early
passage SVZ-NPCs, which could be due to contamination of
residual ependymal cells during SVZ dissection.
The DG lies deep within the hippocampal parenchyma. Type
1 radial glia-like (GFAP+Nestin+) cells are found to have stem934 Neuron 70, 924–938, June 9, 2011 ª2011 Elsevier Inc.cell properties, which can generate type 2a (GFAP-Nestin+)
transient amplifying NPCs that differentiate into type 3 (DCX+)
neuroblasts in the DG (Kriegstein and Alvarez-Buylla, 2009;
Ming and Song, 2005; Seri et al., 2004; Zhao et al., 2008). We
found that Noggin and FXR2 are colocalized in the DG type 1
cells and FXR2 deficiency leads to increased proliferation of
these cells. An ependymal-equivalent cell type has not been
found in the DG. However, the neurons in the DG are in much
closer proximity to stem cells compared with those in the
SVZ; therefore, granule neurons may create a plausible stem
cell niche in the DG, and increased neuronal Noggin expression
in the DG neurons of Fxr2 KO mice may be partially responsible
for the phenotypes of DG-NPCs in Fxr2 KO mice. In summary,
Neuron
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intrinsic properties of NPCs and in the stem cell niche may
contribute to the differences in neurogenesis seen between
the DG and the SVZ.
FXR2, Noggin, and BMP Signaling May be Key
Components of the Mechanism Underlying Differential
Regulation of Adult DG and SVZ NPCs
Noggin plays important roles in many types of stem cells and
helps maintain pluripotency in cultured stem cells (Chambers
et al., 2009; Chaturvedi et al., 2009). With regard to adult neuro-
genesis, Noggin inhibits BMP signaling to promote NPC prolif-
eration and neuronal differentiation, while inhibiting glial differ-
entiation (Chmielnicki et al., 2004; Lim et al., 2000). Our data,
together with previous study (Bonaguidi et al., 2008), suggest
that Noggin and BMP may be key components of the mecha-
nism underlying the differential regulation of DG and SVZ neuro-
genesis. Bonaguidi et al. (2008) demonstrated that DG-NPCs
have a high level of intrinsic BMP signaling and that Noggin
promotes the proliferation of isolated DG-NPCs; they
concluded that Noggin is responsible for maintaining the self-
renewal of type 1 DG stem cells in vivo (Bonaguidi et al.,
2008). This finding is consistent with our observation that Fxr2
KO mice exhibited increased Noggin expression and self-
renewal of Type 1 cells in the DG. Both the findings of Bona-
guidi et al. (2008) and those of the present study show that
Noggin has no effect on the proliferation of SVZ-NPCs;
however, our interpretation of this result is different. Bonaguidi
et al. (2008) proposed that this lack of an effect from Noggin
might be due to the very low level of intrinsic BMP signaling
in SVZ-NPCs, but they did not analyze the effect of Noggin
and BMP on the differentiation of SVZ-NPCs. We found that,
although Noggin has no effect on the proliferation of SVZ-NPCs,
it has similar effects on the differentiation of both DG-NPCs and
SVZ-NPCs, consistent with the literature (Chmielnicki et al.,
2004; Lim et al., 2000). We also found that exogenous BMP2
had similar effects on both the proliferation and differentiation
of both DG-NPCs and SVZ-NPCs. Therefore, our data suggest
that the BMP signal transduction pathway is intact in both DG-
NPCs and SVZ-NPCs. The lack of any effect from Noggin
manipulation on SVZ-NPC proliferation could stem from other
causes, such as the presence of another yet-to-be-identified
inhibitor of BMP signaling in SVZ-NPCs. Based on our data,
we suggest that the main reason FXR2 deficiency has no effect
on SVZ-NPCs is simply because FXR2 does not regulate
Noggin expression in the SVZ.
Posttranscriptional Regulation of Adult Neural Stem
Cells by Fragile X Family RNA-Binding Proteins
Both FMRP and FXR2 are enriched in the brain; however,
mutation of FXR2 has not been associated with human mental
retardation disorders. It is possible that FXR2 mutations in
humans contribute to mild learning deficits without the distinct
features seen in FMRP deficiency. Although FXR2 and FMRP
do not compensate for each other at the protein expression
level; nonetheless, functional compensation between FMRP
and FXR2 has been established clearly in double mutant mice
by their exaggerated behavioral deficits (Bontekoe et al., 2002;Spencer et al., 2006), circadian rhythm changes (Zhang et al.,
2008), and synaptic transmission alterations (Zhang et al.,
2009). On the other hand, evidence also points to different func-
tions for FXR2 and FMRP. For example, loss of FMRPexpression
leads to alterations in long-term synaptic plasticity, including
enhanced mGluR-dependent long-term depression (LTD) in
hippocampal CA1 cells, as well as loss of protein synthesis-
dependence for its maintenance (Hou et al., 2006; Huber et al.,
2002; Nosyreva and Huber, 2006). Surprisingly, Fxr2 KO mice
have decreased mGluR-LTD that remains protein synthesis
dependent, whereas FMRP and FXR2 double mutant mice
have a dramatically exaggerated LTD (Zhang et al., 2009). It is
likely that FXR2 and FMRP are functioning in different pathways
that could synergistically affect certain biological processes,
despite their opposite individual effects. In a similar situation,
we previously showed that FMRP deficiency in mice leads to
impaired hippocampal neurogenesis and hippocampal-depen-
dent learning and that FMRP regulates DG-NPCs via the Wnt
signaling pathway (Guo et al., 2011; Luo et al., 2010). However,
in the current study, we discovered that DG-NPCs in Fxr2 KO
mice have increased neuronal differentiation with no change in
Wnt signaling in Fxr2 KO DG-NPCs. In addition, FMRP inhibits
Gsk3b protein expression by repressing translation without
affecting Gsk3b mRNA stability, whereas FXR2 represses
Noggin protein expression by reducing the stability of Noggin
mRNA. Furthermore, FMRP deficiency results in increased
proliferation of both stem cells and transient amplifying cells in
the adult DG (Luo et al., 2010), and loss of FXR2 only affects
stem cell proliferation in the DG. Therefore, both FMRP and
FXR2 can regulate adult hippocampal NPCs by binding to the
mRNAs of NPC regulators, but their mechanisms, as well as their
functional outputs, are different. Posttranscriptional regulation of
critical regulatory mRNAs by RNA-binding proteins is likely to be
a commonmechanism during critical cellular processes (Bhatta-
charyya et al., 2008; Callan et al., 2010; Tervonen et al., 2009;
Yang et al., 2009), but evidence for this in adult mammalian neu-
rogenesis is rather limited. Our data are among the first to
demonstrate that RNA-binding proteins can play important roles
in the differential regulation of NPCs residing in different adult
brain regions. Future studies examining the role of FXR2 in
generating the inhibitory interneurons of the olfactory bulb and
excitatory neurons of the DG, particularly in comparison with
FMRP, will further contribute to our knowledge of these impor-
tant RNA-binding proteins in adult neurogenesis and plasticity.
EXPERIMENTAL PROCEDURES
Mice
All animal procedures were performed according to protocols approved by the
University of New Mexico Animal Care and Use Committee. The Fxr2 KO
mouse strain on the C57B/L6 genetic background published previously (Bon-
tekoe et al., 2002) was obtained from the Emory University fragile X consor-
tium. The NogginLacZ transgenic mice were maintained and genotyped as
described previously (Stottmann et al., 2001).
In Vivo Cell Proliferation, Differentiation Analysis,
and Immunohistology
In vivo neurogenesis analyses were performed essentially as we have previ-
ously described (Guo et al., 2011; Luo et al., 2010; Smrt et al., 2007; Zhao
et al., 2003). Mice were given four injections of BrdU (50 mg/kg) within 12 hrNeuron 70, 924–938, June 9, 2011 ª2011 Elsevier Inc. 935
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on a published paradigm (Hayes and Nowakowski, 2002). Mice were then
euthanized either at either 12 hr or one week following the final BrdU injection.
Antibody information is provided in Supplemental Experimental Procedures.
Quantification of BrdU+ cells in the DG and SVZ and phenotypic analysis of
BrdU+ cells were performed as described previously.
Isolation, Culture, and In Vitro Analyses of Adult NPCs
NPCs used in this study were isolated from the DG and SVZ of 8- to 10-week-
old male Fxr2 KO mice and WT littermate controls based on published
methods (Babu et al., 2007; Bull and Bartlett, 2005; Luo et al., 2010; Seaberg
and van der Kooy, 2002). NPC maintenance, proliferation and differentiation
analyses, and neurosphere assays were performed as described in our
publications (Barkho et al., 2008; Liu et al., 2010; Luo et al., 2010; Szulwach
et al., 2010).
Cell Transfection and Luciferase Assay
Transfection of NPCs was performed using a Stemfect kit (Stemgent, San
Diego, CA), and luciferase activity was detected using the Dual-Luciferase
Reporter 1000 System (Promega, # E1980), based on the manufacturer’s
protocols and our publications (Liu et al., 2010; Smrt et al., 2010).
In Vivo and In Vitro Acute Knockdown of FXR2 in NPCs
Using FXR2-siRNA
For in vivo acute knockdown of FXR2, retroviral grating was performed as
described (Liu et al., 2010; Smrt et al., 2007; Smrt et al., 2010; Szulwach
et al., 2010).
RNA Immunoprecipitation
RNA-IP was performed as described (Brown et al., 2003; Luo et al., 2010).WT
and Fxr2 KO NPCs (23 106) and a monoclonal antibody against FXR2 (F1554,
Sigma-Aldrich) were used.
RT-PCR, Real-Time PCR, and Neural Stem Cell Pathway Arrays
RT-PCR and real-time PCR were performed using standard methods as
described (Liu et al., 2010; Luo et al., 2010). Differential gene expression in
Fxr2 KO DG-NPCs was determined using mouse Neural Stem Cell Pathway
Arraya (QIAGEN) according to the manufacturer’s instructions (QIAGEN).
Actinomycin D Treatment (Noggin mRNA Stability Assay)
DG-NPCs were treated with 10 mg/ml of actinomycin D (Sigma-Aldrich) to
inhibit gene transcription, based on a published method (Ghosh et al., 2009),
and cells were collected at various time intervals.NogginmRNA levels normal-
ized to GAPDH were assessed by real-time PCR.
In Vitro Transcription of Biotin-Labeled Noggin mRNA
and Binding Assay
Performance of this procedure was based on a previously published method
with minor modifications (Deschenes-Furry et al., 2007).
ELISA Analysis of Secreted Noggin
To determine the amount of secreted Noggin protein in the cell medium,
medium was collected after 24 hr of culture. Determination of secreted
Noggin was performed using a mouse Noggin ELISA kit (ABIN425343,
antibodies-online.com, Atlanta, USA), according to the manufacturer’s
instructions.
Treating NPCs with Exogenous Noggin and BMP2, Anti-Noggin
Blocking Antibody, and Conditioned Medium
For growth factor and antibody treatment, the concentration of Noggin was
250 ng/ml (R&D Systems), BMP2 was 25 ng/ml (R&D Systems), and Noggin
antibody was 2.5 ng/ml (R&D Systems). Conditioned medium was collected
from WT and KO DG-NPCs after 24 hr in culture.
Recombinant Lentivirus and In Vivo Lentiviral Grafting
Lentivirus expressing control shRNA (shCon) was published previously
(Barkho et al., 2008; Liu et al., 2010). Noggin-shRNA plasmids were purchased936 Neuron 70, 924–938, June 9, 2011 ª2011 Elsevier Inc.(QIAGEN), and their efficiency at knocking down endogenous Noggin was
tested by transfecting P19 cells followed by Western blotting analyses. The
shRNA exhibiting highest efficacy was then cloned into the lentiviral vector,
and in vivo lentiviral grafting was performed as described (Liu et al., 2010;
Smrt et al., 2007; Smrt et al., 2010; Szulwach et al., 2010). Based on the pub-
lished criteria (Clelland et al., 2009), only animals with lentivirus-infected
(GFP+) cells in >50% of the DG area of the adult hippocampus were included
in the data analysis shown in Figure 7.
Statistical Analysis
Statistical analysis was performed using ANOVA and Student’s t test, unless
specified, with the aid of SPSS version 17. All percentages were arcsine-trans-
formed before statistical analysis. The Bonferroni correction was used to
control type I error (Rice, 1989). We first normalized the treatment group by
the control group for RT-PCR, and then one-sample t test against mean of 1
was used on the normalized values. All data were shown as mean with stan-
dard error of mean (mean ± SEM). Probabilities of p < 0.05 were considered
as significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes eight figures and Supplemental Experi-
mental Procedures and can be found with this article online at doi:10.1016/j.
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